What is Open Book Extracts?
Founded in 2018 and headquartered in Roxboro, NC, Open Book Extracts (OBX) operates as a cGMP-certified manufacturer of premium plant-based cannabinoid products. The company distinguishes itself by controlling its entire supply chain, from extraction to refinement, utilizing proprietary methods and a robust intellectual property portfolio. With a state-of-the-art extraction campus and a team of Ph.D. chemists and seasoned business leaders, OBX aims to be the industry's benchmark for transparency and quality. Its international arm, OBX Asia, based in Hong Kong, provides localized support for its Asian clientele, facilitating market entry for global brands.
How much funding has Open Book Extracts raised?
Open Book Extracts has raised a total of $11.5M across 1 funding round:
Series B
$11.5M
Series B (2021): $11.5M with participation from KEY Investment Partners and Nortecapital
Key Investors in Open Book Extracts
KEY Investment Partners
KEY Investment Partners is a U.S.-based private equity and venture capital firm focused on the cannabis industry. It invests in high-growth companies across the cannabis value chain, providing both capital and strategic guidance to help businesses scale in a rapidly evolving regulatory market.
Nortecapital
Nortecapital is an investment firm that provides capital and strategic support to companies. Further details on their specific investment focus are not publicly available, but their participation suggests a belief in Open Book Extracts' growth potential.
What's next for Open Book Extracts?
The substantial enterprise-level funding positions Open Book Extracts for significant scaling and further innovation within the burgeoning cannabinoid industry. This strategic investment will likely fuel expansion of its proprietary technologies, enhance its global market reach, and solidify its commitment to industry-leading transparency. The company's focus on controlling the full supply chain, coupled with its growing IP portfolio, suggests a trajectory aimed at capturing a larger share of the premium cannabinoid market and potentially exploring new product development avenues.
See full Open Book Extracts company page
